StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.68−0.02 (-1.18%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

Artelo Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Artelo Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $3.82M, down 37.0% year over year. For fiscal 2025 it was $5.42M, down 9.5% from the year before. The highest annual figure on record is $5.99M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.42M-9.5%
FY2024Dec 31, 2024$5.99M+5.2%
FY2023Dec 31, 2023$5.70M+100.6%
FY2021Aug 31, 2021$2.84M+47.9%
FY2020Aug 31, 2020$1.92M+75.7%
FY2019Aug 31, 2019$1.09M-12.6%
FY2018Aug 31, 2018$1.25M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$876.00K-53.2%
Q1 FY2026CQ1 2026Mar 31, 2026$773.00K-44.1%
Q4 FY2025CQ4 2025Dec 31, 2025$893.00K-63.9%
Q3 FY2025CQ3 2025Sep 30, 2025$1.28M+292.3%
Q2 FY2025CQ2 2025Jun 30, 2025$1.87M+11.0%
Q1 FY2025CQ1 2025Mar 31, 2025$1.38M-8.2%
Q4 FY2024CQ4 2024Dec 31, 2024$2.48M+16.6%
Q3 FY2024CQ3 2024Sep 30, 2024$325.00K-79.5%
Q2 FY2024CQ2 2024Jun 30, 2024$1.69M+124.1%
Q1 FY2024CQ1 2024Mar 31, 2024$1.51M+22.0%
Q4 FY2023CQ4 2023Dec 31, 2023$2.12M+245.1%
Q3 FY2023CQ3 2023Sep 30, 2023$1.59M+66.6%
Q2 FY2023CQ2 2023Jun 30, 2023$752.00K+13.4%
Q1 FY2023CQ1 2023Mar 31, 2023$1.24M+107.6%
Q4 FY2021CQ3 2021Aug 31, 2021$615.46K+126.2%
Q3 FY2021CQ2 2021May 31, 2021$951.20K+267.7%
Q2 FY2021CQ1 2021Feb 28, 2021$663.36K-8.0%
Q1 FY2021CQ4 2020Nov 30, 2020$595.00K-10.8%
Q4 FY2020CQ3 2020Aug 31, 2020$272.08K+16.4%
Q3 FY2020CQ2 2020May 31, 2020$258.68K+40.4%
Q2 FY2020CQ1 2020Feb 29, 2020$721.31K+47.2%
Q1 FY2020CQ4 2019Nov 30, 2019$666.94K+262.4%
Q4 FY2019CQ3 2019Aug 31, 2019$233.77K-29.7%
Q3 FY2019CQ2 2019May 31, 2019$184.20K-22.2%
Q2 FY2019CQ1 2019Feb 28, 2019$489.98K-24.3%
Q1 FY2019CQ4 2018Nov 30, 2018$184.04K+456.4%
Q4 FY2018CQ3 2018Aug 31, 2018$332.47K–
Q3 FY2018CQ2 2018May 31, 2018$236.85K–
Q2 FY2018CQ1 2018Feb 28, 2018$647.47K–
Q1 FY2018CQ4 2017Nov 30, 2017$33.08K–

More Artelo Biosciences figures

See a number that looks wrong?